as 12-17-2024 4:00pm EST
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.
Founded: | 2008 | Country: | Canada |
Employees: | N/A | City: | N/A |
Market Cap: | 116.6M | IPO Year: | N/A |
Target Price: | N/A | AVG Volume (30 days): | 42.0K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.08 | EPS Growth: | N/A |
52 Week Low/High: | $0.50 - $1.59 | Next Earning Date: | 02-11-2025 |
Revenue: | $29,132 | Revenue Growth: | 8.15% |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
ZTEK Breaking Stock News: Dive into ZTEK Ticker-Specific Updates for Smart Investing
ACCESSWIRE
6 days ago
ACCESSWIRE
9 days ago
ACCESSWIRE
21 days ago
Simply Wall St.
a month ago
ACCESSWIRE
a month ago
ACCESSWIRE
2 months ago
Simply Wall St.
2 months ago
ACCESSWIRE
2 months ago
The information presented on this page, "ZTEK Zentek Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.